CULLINAN ONCOLOGY

Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.

CULLINAN ONCOLOGY

Social Links:

Industry:

Biopharma Biotechnology Medical Device

Founded:

2017-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.cullinanoncology.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

389.7 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

antengene-corporation-logo

Antengene Corporation

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

cyteir-therapeutics-logo

Cyteir Therapeutics

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

sesen-bio-inc-logo

Sesen Bio, Inc.

Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

navitor-pharmaceuticals-logo

Navitor Pharmaceuticals

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

prelude-therapeutics-logo

Prelude Therapeutics

Prelude Therapeutics is a developer of novel therapies intended to target key drivers of cancer cell growth, survival and resistance.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

Current Advisors List

briggs-morrison_image

Briggs Morrison Board of advisors @ Cullinan Oncology
Advisor

brian-pereira_image

Brian Pereira Board Member @ Cullinan Oncology
Board_member
2019-05-01

raymond-keane_image

Raymond Keane Board Member @ Cullinan Oncology
Board_member
2019-05-01

timothy-anderson_image

Timothy Anderson Board Member @ Cullinan Oncology
Board_member
2020-06-01

asher-page_image

Asher Page Board of directors @ Cullinan Oncology
Board_member
2017-09-01

greg-sieczkiewicz_image

Greg Sieczkiewicz Board of directors @ Cullinan Oncology
Board_member

Current Employees Featured

jon-wigginton_image

Jon Wigginton
Jon Wigginton Chairman SAB and Senior Advisor @ Cullinan Oncology
Chairman SAB and Senior Advisor
2021-05-01

mark-melville_image

Mark Melville
Mark Melville Vice President @ Cullinan Oncology
Vice President
2020-12-01

corinne-savill_image

Corinne Savill
Corinne Savill Chief Business Officer @ Cullinan Oncology
Chief Business Officer
2017-02-01

leigh-zawel_image

Leigh Zawel
Leigh Zawel Chief Scientific Officer @ Cullinan Oncology
Chief Scientific Officer
2017-08-01

k-dane-wittrup_image

K. Dane Wittrup
K. Dane Wittrup Co-founder, Cullinan Amber LLC @ Cullinan Oncology
Co-founder, Cullinan Amber LLC
2020-04-01

patrick-baeuerle_image

Patrick Baeuerle
Patrick Baeuerle CSO & Co-Founder @ Cullinan Oncology
CSO & Co-Founder

nadim-ahmed_image

Nadim Ahmed
Nadim Ahmed President & CEO @ Cullinan Oncology
President & CEO
2021-10-01

jacquelyn-sumer_image

Jacquelyn Sumer
Jacquelyn Sumer Chief Legal Officer, Corporate Secretary, Chief Compliance Officer @ Cullinan Oncology
Chief Legal Officer, Corporate Secretary, Chief Compliance Officer
2022-08-01

not_available_image

Jeffrey Trigilio
Jeffrey Trigilio Chief Financial Officer @ Cullinan Oncology
Chief Financial Officer
2020-09-01

Founder

k-dane-wittrup_image

K. Dane Wittrup

patrick-baeuerle_image

Patrick Baeuerle

Stock Details

Company's stock symbol is NASDAQ:CGEM

Investors List

foresite-capital_image

Investments List

Date	Company	Article	Money raised
2019-02-05	Cullinan Pearl	Cullinan Oncology investment in Series A - Cullinan Pearl	N/A

Key Employee Changes

Date	New article
2022-08-15	Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer
2021-10-18	Cullinan Oncology Appoints Nadim Ahmed as Chief Executive Officer

Official Site Inspections

http://www.cullinanoncology.com Semrush global rank: 4.15 M Semrush visits lastest month: 2.87 K

Host Informations
Whois Informations

Loading ...

America

Europe

Asia

Others

CULLINAN ONCOLOGY

CULLINAN ONCOLOGY

Social Links:

Industry:

Founded:

Address:

Country:

Website Url:

Total Employee:

Status:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

Current Advisors List

Current Employees Featured

Founder

Stock Details

Investors List

Investments List

Key Employee Changes

Official Site Inspections

More informations about "Cullinan Oncology" on Search Engine